Literature DB >> 21647683

Normal sensory and absent cognitive electrophysiological responses in functional visual loss following chemical eye burn.

Nada Jiraskova1, Miroslav Kuba, Jan Kremlacek, Pavel Rozsival.   

Abstract

OBJECTIVE: To present a unique case of a 34-year-old patient with unilateral functional visual loss after chemical burn with normal visual evoked potentials (VEPs) and absent cognitive response (P300 wave).
METHODS: Visual functions, complete ophthalmic and neurologic examinations including computed tomography of the brain, electrophysiological testing of the visual pathway up to the cognitive brain cortex were evaluated. Data were collected prospectively during 1-year follow-up and compared with data from published case series and a literature review.
RESULTS: No abnormalities were found that could account for such a rapid monocular loss of vision with exception of absence of the P300 wave in the affected eye during cognitive tasks. Vision slowly improved during 1 year without any treatment.
CONCLUSIONS: Functional vision loss is a diagnosis of exclusion. In the event of reduced vision in the context of a normal ocular health examination, all other pathology must be ruled out before the diagnosis of functional visual loss is established. Complex visual electrophysiological testing is the preferred tool for objective examination of such disorders.

Entities:  

Mesh:

Year:  2011        PMID: 21647683     DOI: 10.1007/s10633-011-9275-0

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  20 in total

Review 1.  Medically unexplained symptoms and syndromes.

Authors:  Michael Sharpe
Journal:  Clin Med (Lond)       Date:  2002 Nov-Dec       Impact factor: 2.659

2.  Visual evoked potentials specific for motion onset.

Authors:  M Kuba; Z Kubová
Journal:  Doc Ophthalmol       Date:  1992       Impact factor: 2.379

3.  Motion-onset VEPs reflect long maturation and early aging of visual motion-processing system.

Authors:  J Langrová; M Kuba; J Kremlácek; Z Kubová; F Vít
Journal:  Vision Res       Date:  2005-08-03       Impact factor: 1.886

Review 4.  Motion-onset VEPs: characteristics, methods, and diagnostic use.

Authors:  M Kuba; Z Kubová; J Kremlácek; J Langrová
Journal:  Vision Res       Date:  2006-11-28       Impact factor: 1.886

Review 5.  A primer on motion visual evoked potentials.

Authors:  Sven P Heinrich
Journal:  Doc Ophthalmol       Date:  2007-02-16       Impact factor: 2.379

6.  Contrast dependence of motion-onset and pattern-reversal evoked potentials.

Authors:  Z Kubová; M Kuba; H Spekreijse; C Blakemore
Journal:  Vision Res       Date:  1995-01       Impact factor: 1.886

7.  Effect of memantine in Alzheimer's disease evaluated by visual-evoked potentials to pattern-reversal, motion-onset, and cognitive stimuli.

Authors:  Zuzana Kubová; Jan Kremláček; Martin Vališ; Jana Szanyi; Jana Langrová; František Vít; Miroslav Kuba
Journal:  J Clin Neurophysiol       Date:  2010-10       Impact factor: 2.177

Review 8.  Systematic review of misdiagnosis of conversion symptoms and "hysteria".

Authors:  Jon Stone; Roger Smyth; Alan Carson; Steff Lewis; Robin Prescott; Charles Warlow; Michael Sharpe
Journal:  BMJ       Date:  2005-10-13

9.  Functional vision loss: a diagnosis of exclusion.

Authors:  Rex B Villegas; Pauline F Ilsen
Journal:  Optometry       Date:  2007-10

10.  The utility of clinical electrophysiology in a case of nonorganic vision loss.

Authors:  Avesh Raghunandan; Robert S Buckingham
Journal:  Optometry       Date:  2008-08
View more
  2 in total

1.  Objective measurement of visual resolution using the P300 to self-facial images.

Authors:  David J Marhöfer; Michael Bach; Sven P Heinrich
Journal:  Doc Ophthalmol       Date:  2015-05-15       Impact factor: 2.379

2.  Faces are more attractive than motion: evidence from two simultaneous oddball paradigms.

Authors:  David J Marhöfer; Michael Bach; Sven P Heinrich
Journal:  Doc Ophthalmol       Date:  2014-03-21       Impact factor: 2.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.